Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo

Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

Samson, M., Libert, F., Doranz, B. J., Rucker, J. B., Liesnard, C., Farber, C., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,885 · see citing works

Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation

Hütter, G., Nowak, D., Mossner, M., Ganepola, S., Muessig, A., Allers, K., Schneider, T., Hofmann, J., Kücherer, C., Blau, O., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0802905 · Cited by 1,837 · see citing works

CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract

Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., Nguyen, P. L., Khoruts, A., Larson, M. C., Haase, A. T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040874 · Cited by 1,836 · see citing works

Human Lymphoid and Myeloid Cell Development in NOD/LtSz- scid IL2R γ null Mice Engrafted with Mobilized Human Hemopoietic Stem Cells,

Shultz, L. D., Lyons, B. L., Burzenski, L. M., Gott, B., Chen, X., Chaleff, S., Kotb, M., Gillies, S. D., King, M., Mangada, J., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6477 · Cited by 1,736 · see citing works

Highly efficient endogenous human gene correction using designed zinc-finger nucleases

Urnov, F. D., Miller, J. C., Lee, Y.-L., Beausejour, C. M., Rock, J. M., Augustus, S., Jamieson, A. C., Porteus, M. H., Gregory, P. D., & Holmes, M. C. (2005) · Nature · doi:10.1038/nature03556 · Cited by 1,642 · see citing works

Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy

Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508 · see citing works

Gastrointestinal Tract as a Major Site of CD4 + T Cell Depletion and Viral Replication in SIV Infection

Veazey, R. S., DeMaria, M. A., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., & Lackner, A. A. (1998) · Science · doi:10.1126/science.280.5362.427 · Cited by 1,404 · see citing works

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

Mattapallil, J. J., Douek, D. C., Hill, B. J., Nishimura, Y., Martin, M. A., & Roederer, M. (2005) · Nature · doi:10.1038/nature03501 · Cited by 1,269 · see citing works

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1

Ott, M., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kühlcke, K., Schilz, A. J., Kunkel, H., et al. (2006) · Nature Medicine · doi:10.1038/nm1393 · Cited by 1,189 · see citing works

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5

Wu, L., Gerard, N. P., Wyatt, R. T., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., et al. (1996) · Nature · doi:10.1038/384179a0 · Cited by 1,168 · see citing works

Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning

Aiuti, A., Slavin, S., Aker, M., Ficara, F., Deola, S., Mortellaro, A., Morecki, S., Andolfi, G., Tabucchi, A., Carlucci, F., et al. (2002) · Science · doi:10.1126/science.1070104 · Cited by 1,137 · see citing works

Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency

Aiuti, A., Cattaneo, F., Galimberti, S., Benninghoff, U., Cassani, B., Callegaro, L., Scaramuzza, S., Andolfi, G., Mirolo, M., Brigida, I., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805817 · Cited by 1,003 · see citing works

Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases

Perez, E. E., Wang, J., Miller, J. C., Jouvenot, Y., Kim, K. A., Liu, O., Wang, N., Lee, G., Bartsevich, V. V., Lee, Y.-L., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1410 · Cited by 999 · see citing works

Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates

Mátés, L., Chuah, M., Belay, E., Jerchow, B., Manoj, N., Acosta‐Sanchez, A., Grzela, D. P., Schmitt, A., Becker, K., Mátrai, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.343 · Cited by 951 · see citing works

Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells

Li, Q., Duan, L., Estes, J. D., Ma, Z.-M., Rourke, T., Wang, Y., Reilly, C., Carlis, J. V., Miller, C. J., & Haase, A. T. (2005) · Nature · doi:10.1038/nature03513 · Cited by 950 · see citing works

Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice

Ishikawa, F., Yasukawa, M., Lyons, B. L., Yoshida, S., Miyamoto, T., Yoshimoto, G., Watanabe, T., Akashi, K., Shultz, L. D., & Harada, M. (2005) · Blood · doi:10.1182/blood-2005-02-0516 · Cited by 933 · see citing works

Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases

Doyon, Y., McCammon, J. M., Miller, J. C., Faraji, F., Ngo, C., Katibah, G. E., Amora, R., Hocking, T. D., Zhang, L., Rebar, E. J., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1409 · Cited by 896 · see citing works

Severe CD4⁺T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy

Guadalupe, M., Reay, E., Sankaran, S., Prindiville, T., Flamm, J., McNeil, A., & Dandekar, S. (2003) · Journal of Virology · doi:10.1128/jvi.77.21.11708-11717.2003 · Cited by 866 · see citing works

Targeted Chromosomal Cleavage and Mutagenesis in Drosophila Using Zinc-Finger Nucleases

Bibikova, M., Golic, M., Golic, K. G., & Carroll, D. (2002) · Genetics · doi:10.1093/genetics/161.3.1169 · Cited by 860 · see citing works

Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery

Lombardo, A., Genovese, P., Beausejour, C. M., Colleoni, S., Lee, Y.-L., Kim, K. A., Ando, D., Urnov, F. D., Galli, C., Gregory, P. D., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1353 · Cited by 845 · see citing works

The Challenge of Finding a Cure for HIV Infection

Richman, D. D., Margolis, D. M., Delaney, M., Greene, W. C., Hazuda, D. J., & Pomerantz, R. J. (2009) · Science · doi:10.1126/science.1165706 · Cited by 840 · see citing works

Immune activation and inflammation in HIV‐1 infection: causes and consequences

Appay, V., & Sauce, D. (2007) · The Journal of Pathology · doi:10.1002/path.2276 · Cited by 742 · see citing works

Acute Human Immunodeficiency Virus Type 1 Infection

Kahn, J. S., & Walker, B. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390107 · Cited by 728 · see citing works

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

Palmer, S., Maldarelli, F. M., Wiegand, A. P., Bernstein, B. M., Hanna, G. J., Brun, S. C., Kempf, D. J., Mellors, J. W., Coffin, J. M., & King, M. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800050105 · Cited by 636 · see citing works

HIV disease: fallout from a mucosal catastrophe?

Brenchley, J. M., Price, D. A., & Douek, D. C. (2006) · Nature Immunology · doi:10.1038/ni1316 · Cited by 579 · see citing works

T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice

Kumar, P., Ban, H., Kim, S. S., Wu, H., Pearson, T., Greiner, D. L., Laouar, A., Yao, J., Haridas, V., Habiro, K., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.034 · Cited by 573 · see citing works

Persistence of HIV in Gut‐Associated Lymphoid Tissue despite Long‐Term Antiretroviral Therapy

Chun, T., Nickle, D. C., Justement, J. S., Meyers, J. H., Roby, G. A., Hallahan, C. W., Kottilil, S., Moir, S. L., Mican, J. M., Mullins, J. I., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/527324 · Cited by 569 · see citing works

CCR5 deficiency increases risk of symptomatic West Nile virus infection

Glass, W. G., McDermott, D., Lim, J. K., Lekhong, S., Yu, S., Frank, W. A., Pape, J., Cheshier, R. C., & Murphy, P. (2006) · Journal of Experimental Medicine · doi:10.1084/jem.20051970 · Cited by 543 · see citing works

Differential usage of non-homologous end-joining and homologous recombination in double strand break repair

Sonoda, E., Hochegger, H., Saberi, A., Taniguchi, Y., & Takeda, S. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.05.022 · Cited by 527 · see citing works

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

Dinoso, J. B., Kim, S. Y., Wiegand, A. P., Palmer, S., Gange, S. J., Cranmer, L. M., O'Shea, A., Callender, M., Spivak, A. M., Brennan, T. P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903107106 · Cited by 439 · see citing works

Genetic manipulation of genomes with rare-cutting endonucleases

Jasin, M. (1996) · Trends in Genetics · doi:10.1016/0168-9525(96)10019-6 · Cited by 391 · see citing works

HIV-1 infection in an individual homozygous for the CCR5 deletion allele

Biti, R. A., Ffrench, R. A., Young, J. M., et al. (1997) · Nature Medicine · doi:10.1038/nm0397-252 · Cited by 359 · see citing works

Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases

Santiago, Y., Chan, E. M., Liu, P., Orlando, S., Zhang, L., Urnov, F. D., Holmes, M. C., Guschin, D. Y., Waite, A. J., Miller, J. C., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800940105 · Cited by 358 · see citing works

Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1

Sun, Z., Denton, P. W., Estes, J. D., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062411 · Cited by 279 · see citing works

Atypical X-Linked Severe Combined Immunodeficiency Due to Possible Spontaneous Reversion of the Genetic Defect in T Cells

Stephan, V., Wahn, V., Deist, F. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611213352104 · Cited by 271 · see citing works

Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry

Loken, M. R., Brosnan, J. M., Bach, B. A., & Ault, K. A. (1990) · Cytometry · doi:10.1002/cyto.990110402 · Cited by 263 · see citing works

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

Mitsuyasu, R. T., Merigan, T. C., Carr, A. D., Zack, J. A., Winters, M. A., Workman, C., Bloch, M. T., Lalezari, J. P., Becker, S., Thornton, L., et al. (2009) · Nature Medicine · doi:10.1038/nm.1932 · Cited by 263 · see citing works

The Geographic Spread of the CCR5 Δ32 HIV-Resistance Allele

Novembre, J., Galvani, A. P., & Slatkin, M. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030339 · Cited by 250 · see citing works

Natural History of HIV-1 Cell-Free Viremia

Henrard, D. R. (1995) · JAMA · doi:10.1001/jama.1995.03530070052029 · Cited by 245 · see citing works

Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting

Rouet, F., Ekouévi, D. K., Chaix, M., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.6.2709-2717.2005 · Cited by 234 · see citing works

Genetic therapies against HIV

Rossi, J. J., June, C. H., & Kohn, D. B. (2007) · Nature Biotechnology · doi:10.1038/nbt1367 · Cited by 233 · see citing works

Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency

Hirschhorn, R., Yang, D. R., Puck, J. M., Huie, M. L., Jiang, C.-K., & Kurlandsky, L. E. (1996) · Nature Genetics · doi:10.1038/ng0796-290 · Cited by 225 · see citing works

Hematopoietic stem cell–engrafted NOD/SCID/IL2Rγnull mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses

Watanabe, S., Terashima, K., Ohta, S., et al. (2006) · Blood · doi:10.1182/blood-2006-04-017681 · Cited by 203 · see citing works

In vivo reversion to normal of inherited mutations in humans

Hirschhorn, R. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.10.721 · Cited by 196 · see citing works

HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-γc-/-(RAG-hu) mouse model

Berges, B. K., Wheat, W. H., Palmer, B. E., et al. (2006) · Retrovirology · doi:10.1186/1742-4690-3-76 · Cited by 171 · see citing works

Immunopathogenesis of acute AIDS virus infection

Picker, L. J. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.05.001 · Cited by 158 · see citing works

Distribution of Health Care Expenditures for HIV-Infected Patients

Chen, R. Y., Accortt, N. A., Westfall, A. O., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/500453 · Cited by 153 · see citing works

The mucosal immune system: primary target for HIV infection and AIDS

Veazey, R. S., Marx, P. A., & Lackner, A. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02039-7 · Cited by 133 · see citing works

Stable gene transfer and expression in cord blood–derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system

Xue, X., Huang, X., Nodland, S. E., Mátés, L., Ma, L., Izsvák, Z., Ivics, Z., LeBien, T. W., McIvor, R. S., Wagner, J. E., et al. (2009) · Blood · doi:10.1182/blood-2009-03-210005 · Cited by 126 · see citing works

Safety and Efficacy of a Lentiviral Vector Containing Three Anti-HIV Genes—CCR5 Ribozyme, Tat-rev siRNA, and TAR Decoy—in SCID-hu Mouse–Derived T Cells

Anderson, J. S., Li, M.-J., Palmer, B. E., Remling‐Mulder, L., Li, S. X., Yam, P. Y., Yee, J., Rossi, J. J., Zaia, J. A., & Akkina, R. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300157 · Cited by 111 · see citing works

A Mechanism for the Impaired IFN-γ Production in C-C Chemokine Receptor 2 (CCR2) Knockout Mice: Role of CCR2 in Linking the Innate and Adaptive Immune Responses

Peters, W., Dupuis, M., & Charo, I. F. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7072 · Cited by 108 · see citing works

The Gastrointestinal Tract and AIDS Pathogenesis

Lackner, A. A., Mohan, M., & Veazey, R. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.071 · Cited by 103 · see citing works

Characterization of Anti-CCR5 Ribozyme-Transduced CD34+ Hematopoietic Progenitor Cells in Vitro and in a SCID-hu Mouse Model in Vivo

Bai, J., Gorantla, S., Banda, N. K., Cagnon, L., Rossi, J. J., & Akkina, R. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0038 · Cited by 99 · see citing works

CCR2 chemokine receptor and AIDS progression

Smith, M. W., Carrington, M. N., Winkler, C. A., Lomb, D. A., Dean, M. C., Huttley, G. A., & O’Brien, S. J. (1997) · Nature Medicine · doi:10.1038/nm1097-1052c · Cited by 99 · see citing works

CC Chemokine Receptor 5 Cell-Surface Expression in Relation to CC Chemokine Receptor 5 Genotype and the Clinical Course of HIV-1 Infection

Husman, A. D. R., Blaak, H., Brouwer, M., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4597 · Cited by 98 · see citing works

Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120

Ogert, R. A., Wojcik, L., Buontempo, C. A., Ba, L., Buontempo, P. J., Ralston, R., Strizki, J., & Howe, J. A. (2008) · Virology · doi:10.1016/j.virol.2007.12.009 · Cited by 89 · see citing works

Autologous stem cell transplantation for HIV-associated lymphoma

Krishnan, A. Y., Molina, A., Zaia, J. A., et al. (2001) · Blood · doi:10.1182/blood.v98.13.3857 · Cited by 85 · see citing works

T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery

Swan, C. H., Bühler, B., Tschan, M. P., Barbas, C. F., & Torbett, B. E. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302801 · Cited by 83 · see citing works

Impact of Inversion of the CD4/CD8 Ratio on the Natural History of HIV-1 Infection

Margolick, J. B., Gange, S. J., Detels, R., et al. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000223028.55080.9d · Cited by 74 · see citing works

HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy

Weiser, B., Philpott, S. M., Klimkait, T., Burger, H., Ramirez, C. M., Bürgisser, P., Gorgievski, M., Perrin, L. H., Piffaretti, J.-C., & Ledergerber, B. (2008) · AIDS · doi:10.1097/qad.0b013e3282f4196c · Cited by 66 · see citing works

Stable gene transfer to human CD34+ hematopoietic cells using the Sleeping Beauty transposon

Hollis, R. P., Nightingale, S. J., Wang, X., Pepper, K. A., Yu, X., Barsky, L. W., Crooks, G. M., & Kohn, D. B. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.05.023 · Cited by 56 · see citing works

Novel Targets for Antiretroviral Therapy

Dau, B., & Holodniy, M. (2009) · Drugs · doi:10.2165/00003495-200969010-00003 · Cited by 55 · see citing works

Revertant somatic mosaicism in the Wiskott–Aldrich syndrome

Davis, B. R., & Candotti, F. (2009) · Immunologic Research · doi:10.1007/s12026-008-8091-4 · Cited by 54 · see citing works

Stable Transgene Expression in Primitive Human CD34 + Hematopoietic Stem/Progenitor Cells, Using the Sleeping Beauty Transposon System

Sumiyoshi, T., Holt, N. G., Hollis, R. P., Ge, S., Cannon, P. M., Crooks, G. M., & Kohn, D. B. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.109 · Cited by 50 · see citing works

IFN-α-Induced Upregulation of CCR5 Leads to Expanded HIV Tropism In Vivo

Stoddart, C. A., Keir, M. E., & McCune, J. M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000766 · Cited by 47 · see citing works

CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual

Oh, D., Jessen, H. K., Kücherer, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002747 · Cited by 43 · see citing works

Negative association of the chemokine receptor CCR5 d32 polymorphism with systemic inflammatory response, extra-articular symptoms and joint erosion in rheumatoid arthritis

Rossol, M., Pierer, M., Arnold, S., et al. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2733 · Cited by 36 · see citing works

CCR5Δ32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis

Kantarci, O. H., Morales, Y., Ziemer, P. A., Hebrink, D. D., Mahad, D., Atkinson, E. J., Achenbach, S. J., de Andrade, M., Mack, M., Ransohoff, R. M., et al. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.07.025 · Cited by 35 · see citing works

Transplantation of selected or transgenic blood stem cells – a future treatment for HIV/AIDS?

Hütter, G., Schneider, T., & Thiel, E. (2009) · Journal of the International AIDS Society · doi:10.1186/1758-2652-12-10 · Cited by 31 · see citing works

CCR5 Ligands Modulate CXCL12-Induced Chemotaxis, Adhesion, and Akt Phosphorylation of Human Cord Blood CD34+ Cells

Basu, S., & Broxmeyer, H. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900542 · Cited by 28 · see citing works

Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients

Soulié, C., Malet, I., Lambert-Niclot, S., et al. (2008) · AIDS · doi:10.1097/qad.0b013e328313bf9c · Cited by 27 · see citing works

R5 Human Immunodeficiency Virus Type 1 Infection of Fetal Thymic Organ Culture Induces Cytokine and CCR5 Expression

Choudhary, S. K., Choudhary, N. R., Kimbrell, K., Colasanti, J. A., Ziogas, A., Kwa, D., Schuitemaker, H., & Camerini, D. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.458-471.2005 · Cited by 20 · see citing works

Effect of HIV-1 Infection on Lymphocyte Proliferation in Gut-Associated Lymphoid Tissue

Talal, A. H., Irwin, C. E., Dieterich, D. T., et al. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200103010-00002 · Cited by 14 · see citing works

Can gene delivery close the door to HIV‐1 entry after escape?

Swan, C. H., & Torbett, B. E. (2006) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2006.00172.x · Cited by 11 · see citing works

Effect of HIV-1 Infection on Lymphocyte Proliferation in Gut-Associated Lymphoid Tissue

Talal, A. H., Irwin, C. E., Dieterich, D. T., et al. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200103010-00002 · Cited by 11 · see citing works

RNA-Guided Human Genome Engineering via Cas9

Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · see citing works

ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering

Gaj, T., Gersbach, C. A., & Barbas, C. F. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.04.004 · Cited by 3,820 · see citing works

Genome editing with engineered zinc finger nucleases

Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285 · see citing works

A TALE nuclease architecture for efficient genome editing

Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098 · see citing works

Gene Editing of <i>CCR5</i> in Autologous CD4 T Cells of Persons Infected with HIV

Tebas, P., Stein, D., Tang, W. W., Frank, I., Wang, S. Q., Lee, G., Spratt, S. K., Surosky, R. T., Giedlin, M. A., Nichol, G., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1300662 · Cited by 1,357 · see citing works

A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity

Mussolino, C., Morbitzer, R., Lütge, F., Dannemann, N., Lahaye, T., & Cathomen, T. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr597 · Cited by 714 · see citing works

Targeted genome editing in human repopulating haematopoietic stem cells

Genovese, P., Schiroli, G., Escobar, G., Di Tomaso, T., Firrito, C., Calabria, A., Moi, D., Mazzieri, R., Bonini, C., Holmes, M. C., et al. (2014) · Nature · doi:10.1038/nature13420 · Cited by 555 · see citing works

Highly efficient therapeutic gene editing of human hematopoietic stem cells

Wu, Y., Zeng, J., Roscoe, B. P., Liu, P., Yao, Q., Lazzarotto, C. R., Clement, K., Cole, M. A., Luk, K., Baricordi, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0401-y · Cited by 515 · see citing works

Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9

Mandal, P. K., Ferreira, L. M. R., Collins, R., Meissner, T. B., Boutwell, C. L., Friesen, M., Vrbanac, V., Garrison, B. S., Stortchevoi, A., Bryder, D., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.10.004 · Cited by 475 · see citing works

Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures

Doyon, Y., Vo, T. D., Mendel, M. C., Greenberg, S. G., Wang, J., Xia, D. F., Miller, J. C., Urnov, F. D., Gregory, P. D., & Holmes, M. C. (2011) · Nature Methods · doi:10.1038/nmeth.1539 · Cited by 402 · see citing works

Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells

Hoban, M. D., Cost, G. J., Mendel, M. C., Romero, Z., Kaufman, M. L., Joglekar, A. V., Ho, M., Lumaquin, D., Gray, D., Lill, G. R., et al. (2015) · Blood · doi:10.1182/blood-2014-12-615948 · Cited by 320 · see citing works

Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection

Ye, L., Wang, J., Beyer, A. I., Teque, F., Cradick, T. J., Qi, Z., Chang, J. C., Bao, G., Muench, M. O., Yu, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407473111 · Cited by 320 · see citing works

Targeted gene knockout by direct delivery of zinc-finger nuclease proteins

Gaj, T., Guo, J., Kato, Y., Sirk, S. J., & Barbas, C. F. (2012) · Nature Methods · doi:10.1038/nmeth.2030 · Cited by 306 · see citing works

Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors

Wang, J., Exline, C. M., DeClercq, J. J., Llewellyn, G. N., Hayward, S. B., Li, P. W.-L., Shivak, D. A., Surosky, R. T., Gregory, P. D., Holmes, M. C., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3408 · Cited by 261 · see citing works

A New Class of Medicines through DNA Editing

Porteus, M. H. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1800729 · Cited by 229 · see citing works

A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells

Hultquist, J. F., Schumann, K., Woo, J. M., Manganaro, L., McGregor, M. J., Doudna, J., Simon, V., Krogan, N. J., & Marson, A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.080 · Cited by 170 · see citing works

New cell sources for T cell engineering and adoptive immunotherapy

Themeli, M., Rivière, I., & Sadelain, M. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.03.011 · Cited by 179 · see citing works

Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases

Li, L., Krymskaya, L., Wang, J., Henley, J., Rao, A., Cao, L.-F., Tran, C.-A., Torres-Coronado, M., Gardner, A., Gonzalez, N., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.65 · Cited by 181 · see citing works

HIV reservoirs: pathogenesis and obstacles to viral eradication and cure

Chun, T.-W., & Fauci, A. S. (2012) · AIDS · doi:10.1097/qad.0b013e328353f3f1 · Cited by 175 · see citing works

Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells

Qu, X., Wang, P., Ding, D., Li, L., Wang, H., Ma, L., Zhou, X., Liu, S., Lin, S., Wang, X., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt571 · Cited by 155 · see citing works

Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases

Wilen, C. B., Wang, J., Tilton, J. C., Miller, J. C., Kim, K. A., Rebar, E. J., Sherrill-Mix, S. A., Patro, S. C., Secreto, A. J., Jordan, A. P. O., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002020 · Cited by 142 · see citing works

Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6

Bak, R. O., Dever, D. P., Reinisch, A., Cruz Hernandez, D., Majeti, R., & Porteus, M. H. (2017) · eLife · doi:10.7554/elife.27873 · Cited by 122 · see citing works

Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5

Maier, D. A., Brennan, A. L., Jiang, S., Binder-Scholl, G. K., Lee, G., Plesa, G., Zheng, Z., Cotte, J., Carpenito, C., Wood, T., et al. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.172 · Cited by 126 · see citing works

Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichment

Yuan, J., Wang, J., Crain, K., Fearns, C., Kim, K. A., Hua, K. L., Gregory, P. D., Holmes, M. C., & Torbett, B. E. (2012) · Molecular Therapy · doi:10.1038/mt.2011.310 · Cited by 105 · see citing works

Newer Gene Editing Technologies toward HIV Gene Therapy

Manjunath, N., Yi, G., Dang, Y., & Shankar, P. (2013) · Viruses · doi:10.3390/v5112748 · Cited by 77 · see citing works

Generation of an HIV resistant T-cell line by targeted “stacking” of restriction factors

Voit, R. A., McMahon, M. A., Sawyer, S. L., & Porteus, M. H. (2013) · Molecular Therapy · doi:10.1038/mt.2012.284 · Cited by 74 · see citing works

Towards a new era in medicine: therapeutic genome editing

Porteus, M. H. (2015) · Genome Biology · doi:10.1186/s13059-015-0859-y · Cited by 69 · see citing works

Integrase-defective Lentiviral Vectors as a Delivery Platform for Targeted Modification of Adenosine Deaminase Locus

Joglekar, A. V., Hollis, R. P., Kuftinec, G., Senadheera, S., Chan, R., & Kohn, D. B. (2013) · Molecular Therapy · doi:10.1038/mt.2013.106 · Cited by 65 · see citing works

Targeted gene disruption to cure HIV

Stone, D., Kiem, H.-P., & Jerome, K. R. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835f736c · Cited by 55 · see citing works

A novel therapeutic molecule against HTLV-1 infection targeting provirus

Tanaka, A., Takeda, S., Kariya, R., Matsuda, K., Urano, E., Okada, S., & Komano, J. (2013) · Leukemia · doi:10.1038/leu.2013.46 · Cited by 46 · see citing works

Pre-clinical Modeling of CCR5 Knockout in Human Hematopoietic Stem Cells by Zinc Finger Nucleases Using Humanized Mice

Hofer, U., Henley, J. E., Exline, C. M., Mulhern, O., Lopez, E., & Cannon, P. M. (2013) · Journal of Infectious Diseases · doi:10.1093/infdis/jit382 · Cited by 43 · see citing works

The Alpha Stem Cell Clinic: A Model for Evaluating and Delivering Stem Cell-Based Therapies

Trounson, A., DeWitt, N. D., & Feigal, E. G. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0027 · Cited by 33 · see citing works

Proviral HIV-genome-wide and pol-gene specific zinc finger nucleases: Usability for targeted HIV gene therapy

Wayengera, M. (2011) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-8-26 · Cited by 21 · see citing works

High frequency CCR5 editing in human hematopoietic stem progenitor cells protects xenograft mice from HIV infection

Claiborne, D. T., Detwiler, Z., Docken, S. S., Borland, T. D., Cromer, D., Simkhovich, A., Ophinni, Y., Okawa, K., Bateson, T., Chen, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-55873-3 · Cited by 16 · see citing works

Genome Editing for the β-Hemoglobinopathies

Porteus, M. H. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-7299-9_8 · Cited by 8 · see citing works

Evolution of prime editing systems: move forward to the treatment of hereditary diseases

Volodina, O. V., Fabrichnikova, A. R., Anuchina, A. A., Mishina, O. S., Lavrov, A. V., & Smirnikhina, S. A. (2025) · Current Gene Therapy · doi:10.2174/0115665232295117240405070809 · Cited by 1 · see citing works

Construction of Artificial Zinc Finger Libraries and Application in Screening Zinc Finger Nucleases

Yang, H. (2012) · Xibei nongye xuebao

Structure based design of protein linkers for zinc finger nuclease

Anand, P., Schug, A. H., & Wenzel, W. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.08.015 · Cited by 16 · see citing works

Electronic Design and Structure Simulation of Artificial Zinc Finger Nucleases

Wen-jun, S. (2011) · Research and Exploration in Laboratory

Using defined finger–finger interfaces as units of assembly for constructing zinc-finger nucleases

Zhu, C., Gupta, A., Hall, V. L., Rayla, A. L., Christensen, R. G., Dake, B. T., Lakshmanan, A., Kuperwasser, C., Stormo, G. D., & Wolfe, S. A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1357 · Cited by 31 · see citing works

Improved DNA binding specil finger peptides by using strir two-finger units

Moore, M. J. B., Klug, A., & Choo, Y. (2016)